Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expanding non‐invasive prenatal testing beyond chromosomes 21, 18, 13, X and Y

10 Jun 2016

Abstract excerpt

Non-invasive prenatal testing (NIPT) based on cell-free DNA in maternal plasma is being expanded to include additional chromosome abnormalities beyond those involving chromosomes 21, 18, 13, X and Y. Review of population cytogenetic data provides insight into the likely number of additional abnormalities detectable. Additional clinically significant and cytogenetically recognizable abnormalities are present in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomic variations and chromosomal abnormalities
Share to Prenatal Screening and Diagnostics
Share to Tumors and Oncological Cases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27283893
DOI: 10.1111/cge.12818

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expanding non‐invasive prenatal testing beyond chromosomes 21, 18, 13, X and YPMID 27283893Read ↗

Non‐invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnanciesSemantic proximity Read ↗

Clinical application of expanded noninvasive prenatal testing for fetal chromosome abnormalities in a cohort of 39,580 pregnanciesSemantic proximity Read ↗

Genome‐wide non‐invasive prenatal screening for all cytogenetically visible imbalancesSemantic proximity Read ↗

Overview of Noninvasive Prenatal Testing (NIPT) for the Detection of Fetal Chromosome Abnormalities; Differences in Laboratory Methods and Scope of TestingSemantic proximity Read ↗

Non-invasive prenatal testing: a revolutionary journey in prenatal testingSemantic proximity Read ↗

Clinical Validation of a Non-Invasive Prenatal Test for Genome-Wide Detection of Fetal Copy Number VariantsSemantic proximity Read ↗

Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental diseaseSemantic proximity Read ↗

Clinical implementation of NIPT – technical and biological challengesSemantic proximity Read ↗

Current controversies in prenatal diagnosis: Expanded NIPT that includes conditions other than trisomies 13, 18, and 21 should be offeredSemantic proximity Read ↗

Cell-Free DNA Screening for Sex Chromosome Abnormalities and Pregnancy Outcomes, 2018–2020: A Retrospective AnalysisSemantic proximity Read ↗

Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variantsSemantic proximity Read ↗

Non-Invasive Prenatal Chromosomal Aneuploidy Testing - Clinical Experience: 100,000 Clinical SamplesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.